Interference in the autoDELFIA(R) hAFP Immunoassay and Effect on Second-Trimester Down's Syndrome Screening

Annals of Clinical Biochemistry - United Kingdom
doi 10.1258/acb.2011.011061
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Maternal Serum CA125 Is Not a Second Trimester Marker for Down's Syndrome

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
1991English

Letter: Screening for Down's Syndrome.

BMJ
1976English

Cost Effectiveness in Screening for Down's Syndrome Still Unclear

BMJ
2002English

Examination of the Pregnancy-Associated Plasma Protein-A Assay on the Beckman Coulter Access® Platform: Suitability for Use in First Trimester Down's Syndrome Screening

Journal of Medical Screening
Health PolicyPublic HealthOccupational HealthEnvironmental
2010English

Down's Syndrome: Screening and Antenatal Diagnosis Regionally in England and Wales 1989–2008

Journal of Medical Screening
Health PolicyPublic HealthOccupational HealthEnvironmental
2010English

First Trimester Concentrations of Pregnancy Associated Plasma Protein a and Placental Protein 14 in Down's Syndrome.

BMJ
1992English

First Trimester Maternal Serum Screening for Down's Syndrome: An Evaluation of the DPC Immulite 2000 Free Β-hCG and Pregnancy-Associated Plasma Protein-A Assays

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2005English

Spermicides and Down's Syndrome.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1982English

Down's Syndrome in Twins

Acta geneticae medicae et gemellologiae
1974English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy